Ajax-Loading

Stryker Corporation - Free Cash Flow To Equity

Stryker Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Free-Cash-Flow-To-Equity" stands at 4.96 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Stryker Corporation's third quarter result of 1.35 Billion USD for the item "Free Cash Flow To Equity" represents an increase of 382.86 percent compared to it's second quarter result.

Also, Stryker Corporation's third quarter result of 1.35 Billion USD for the item "Free Cash Flow To Equity" represents a decrease of -68.43 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Stryker Corporation's third quarter result of 4.96 Billion USD for the item "Free Cash Flow To Equity" represents a decrease of -37.11 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.92 percent compared to the value the year prior.
The 1 year change in percent is 25.92.
The 3 year change in percent is 89.29.
The 5 year change in percent is -25.80.
The 10 year change in percent is 4,255.26.

The Serie's long term average value is 2.73 Billion United States Dollars. It's latest available value, on 09/30/2025, is 82.14 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2015, to it's latest available value, on 09/30/2025, is +4,255.26%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -37.11%.

Free Cash Flow To Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoAbbott Laboratories - Free Cash Flow To Equity217,696,616,448.00
LogoIntuitive Surgical Inc - Free Cash Flow To Equity206,245,888,000.00
LogoEssilorLuxottica S. A. - Free Cash Flow To Equity172,241,486,586.05
LogoDanaher Corporation - Free Cash Flow To Equity162,006,663,168.00
LogoBoston Scientific Corp - Free Cash Flow To Equity144,567,730,176.00